COVID-19 Pandemic in Women–Rheumatologist’s Perspective
COVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with m...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-09-01
|
Series: | Indian Journal of Cardiovascular Disease in Women |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045 |
id |
doaj-859d8f95defc472aa37c7824672b2ebb |
---|---|
record_format |
Article |
spelling |
doaj-859d8f95defc472aa37c7824672b2ebb2020-12-02T18:50:27ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Cardiovascular Disease in Women2455-78542020-09-0150325025510.1055/s-0040-1717045COVID-19 Pandemic in Women–Rheumatologist’s PerspectiveBenzeeta Pinto0Rashmi Roongta1Department of Clinical Immunology and Rheumatology, John’s Medical College, Bengaluru, IndiaDepartment of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, IndiaCOVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with men among the general population. It is not known if the risk is higher in women with RD compared with other women. Currently, published data of COVID-19 in RD suggests similar or mildly increased risk in patients with RD but sex disaggregated data is not available. In this article, we review the current evidence of COVID-19 in RD with an emphasis on women.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045covid 19 in womenrheumatic diseasesimmunosuppressants |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Benzeeta Pinto Rashmi Roongta |
spellingShingle |
Benzeeta Pinto Rashmi Roongta COVID-19 Pandemic in Women–Rheumatologist’s Perspective Indian Journal of Cardiovascular Disease in Women covid 19 in women rheumatic diseases immunosuppressants |
author_facet |
Benzeeta Pinto Rashmi Roongta |
author_sort |
Benzeeta Pinto |
title |
COVID-19 Pandemic in Women–Rheumatologist’s Perspective |
title_short |
COVID-19 Pandemic in Women–Rheumatologist’s Perspective |
title_full |
COVID-19 Pandemic in Women–Rheumatologist’s Perspective |
title_fullStr |
COVID-19 Pandemic in Women–Rheumatologist’s Perspective |
title_full_unstemmed |
COVID-19 Pandemic in Women–Rheumatologist’s Perspective |
title_sort |
covid-19 pandemic in women–rheumatologist’s perspective |
publisher |
Thieme Medical and Scientific Publishers Pvt. Ltd. |
series |
Indian Journal of Cardiovascular Disease in Women |
issn |
2455-7854 |
publishDate |
2020-09-01 |
description |
COVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with men among the general population. It is not known if the risk is higher in women with RD compared with other women. Currently, published data of COVID-19 in RD suggests similar or mildly increased risk in patients with RD but sex disaggregated data is not available. In this article, we review the current evidence of COVID-19 in RD with an emphasis on women. |
topic |
covid 19 in women rheumatic diseases immunosuppressants |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045 |
work_keys_str_mv |
AT benzeetapinto covid19pandemicinwomenrheumatologistsperspective AT rashmiroongta covid19pandemicinwomenrheumatologistsperspective |
_version_ |
1724402985820225536 |